Related Experiment Video

Updated: Jul 30, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.3K

Cyclin-Dependent Kinase Inhibitor 2A/B Homozygous Deletion Prediction and Survival Analysis

Jing Yang1, Lei Li2, Tao Luo2

  • 1Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.

Brain Sciences
|May 16, 2023
PubMed

Insights

Radiomic features can accurately predict Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) homozygous deletion in gliomas. This deletion is a key independent prognostic factor for isocitrate dehydrogenase-mutant low-grade gliomas.

Area of Science:

  • Neuro-oncology
  • Radiomics
  • Molecular Diagnostics

Background:

  • Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) homozygous deletion is a critical prognostic factor in gliomas, influencing treatment decisions.
  • Radiomic features associated with CDKN2A/B homozygous deletion and their prognostic value in low-grade gliomas (LGGs) remain underexplored.
  • Investigating molecular subgroups and radiomics is crucial for understanding prognosis in LGGs.

Purpose of the Study:

  • To develop a predictive model for CDKN2A/B homozygous deletion in gliomas using radiomic features.
  • To assess the prognostic value of CDKN2A/B homozygous deletion and radiomic features in isocitrate dehydrogenase (IDH)-mutant LGGs.
  • To establish reliable prognostic survival models for IDH-mutant LGGs.

Main Methods:

  • Developed a predictive model for CDKN2A/B homozygous deletion in 292 glioma patients using radiomic features.
  • Established prognostic survival models for 104 IDH-mutant LGG patients.
  • Analyzed the independent prognostic value of CDKN2A/B homozygous deletion in LGGs.

Main Results:

  • Radiomic features demonstrated high accuracy and reliability in predicting CDKN2A/B homozygous deletion.
  • CDKN2A/B homozygous deletion was identified as an independent predictor of prognosis in LGGs.
  • The developed models provide essential value for prognostic evaluation in IDH-mutant LGGs.

Conclusions:

  • Radiomics can effectively predict CDKN2A/B homozygous deletion in gliomas.
  • CDKN2A/B homozygous deletion serves as a significant independent prognostic biomarker for LGGs.
  • This study enhances prognostic assessment and treatment strategies for IDH-mutant LGGs.
Keywords:
CDKN2A/B homozygous deletionMRIgliomaradiomicssurvival analysis

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Meiosis II02:02

Meiosis II

Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
45.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
403
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K